DIGITAL medication management app provider, MedAdvisor, has launched a telepharmacy platform to support pharmacists to conduct medication reviews during the COVID-19 pandemic.
The introduction of the new platform follows the Federal Government's announcement that accredited pharmacist can now provide Sixth Community Pharmacy Agreement-funded programs including MedsCheck, Diabetes MedsCheck, Home Medicines Review (HMR) and Residential Medication Management Review (RMMR) services using telepharmacy.
MedAdvisor CEO, Robert Read, said data from the platform would help pharmacists identify and contact eligible patients using the company's PlusOne app, to boost medicines safety during the crisis.
"This announcement is another example of how pharmacists are adapting and innovating to ensure they continue to provide the best healthcare for their communities," he said.
"It also goes a long way towards reducing the risk to pharmacists - our often forgotten frontline of this pandemic - who we need on hand to deliver life-saving medication to our most vulnerable.
"With MedAdvisor network pharmacies recording more than 34,000 MedsChecks and Diabetes MedsChecks between 01 Jan to 31 March this year, there is strong demand for these services in the community and it is imperative that they are not interrupted as a result of COVID-19 self-isolation and social distancing measures.
"By opening these services up to be supported by telepharmacy initiatives we can ensure continuity of care for those most vulnerable in our community."
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Apr 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Apr 20
